Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I feel a 1m+ volume pps spike day coming. Guess is in next couple weeks.
We'll get a closing arguments pr before eom. We'll see a pps boost on that.
Should be at $6+. 2016 prices (split adjusted) before fda hold caused a dump. Their lab is amazing and ready to scale production. Win on arb and they can start gearing up for likely fda approval multikine.
Ya never know on p3. They could surprise and issue results suddenly in near term. Study closed months ago certified.
1. Arb imminent. 30 days from closing statements due possibly within week (April stated). 2. P3 results near. 3. Total share count low and pps not factoring upside correctly.
These are the folks managing arb. Bring in the win lee drucker! http://lakewhillans.com/about/
This is super he sent this out. Not only do we know status on arb (closing and response briefs completed) he says p3 results near. I still contend pps is incredibly low. I may be alone but I admire geert for battling through all these challenges he has faced in last 2 years and he keeps his shareholders regularly informed. I'm patient. Payoff will be well worth it.
To believe no arb is quite the conspiracy theory.
1. Geert has made regular announcements to such. Legal liability to not be truthful at this point with a flood of PRs in last 6 months.
2. The law firm is on contingency. Doubtful they would "make up" a case. They have a lot of incentive to close this out and get paid for accumulated work.
3. New CRO took a huge stock block in lieu of cash payment for years of enrollment work. Insane to think they didn't do due diligence before accepting a lot of stock under false pretenses of arbitration case not occurring.
My guess is arb update soon. Although Inventiv has to be dragging feet here so unknown how long they can pull that off.
yeah. although I expect more volatility here. Market overall is volatile. Not my first buy though. down on other blocks.
*P3 enrollment meant to say
With P3 results complete now and independently certified and so many shares out in open market, a shark like an IOVA could attempt an open market buy out. Why not? They can afford the share rise and would hedge their bets + have synergy in research.
well it could just be they are waiting til april 13th to announce news. After april 12th warrant option extension expires.
Nah I don't have visibility to those buyers unless they take a 5%+ stake. That would have to be reported in a filing. The moment the pr drops for closing statements cvm jumps. Then it's 30 days til outcome. I mean I assume they'll announce closing statements. Unless they just surprise with verdict. Of course this stock is first a gamble on arb. Because it will move. Then p3. I like my timing. I missed all the reverse splits. So I'm not bitter.
I just picked up 4300 more shares. Thanks for negativity everyone!!!
1. December Anson Fund takes a $423K position
https://weekherald.com/2018/03/21/anson-funds-management-lp-invests-423000-in-cel-sci-co-cvm.html
2. 2/14 MM asset mgmt posts 10% share ownership
http://www.conferencecalltranscripts.org/13G/summary/?id=4603528
there's been direct offerings as well
malicious delays inventiv has done could easily lead to punitive type damages. insult to injury.
lol they couldn't get the study even close to working right. The second cro immediately got the enrollment. Inventiv is toast. They were hoping to bankrupt cvm along the way to avoid having to pay out. that clearly won't happen as folks are buying in huge blocks to help cvm.
Reason arb is so protracted is because it is a landmark case. holding a cro responsible for damages of this magnitude is going to set a major precedent. Regardless of outcome the P3 is paramount. Given P1 and P2 were good, and other companies like IOVA are pursuing this type of treatment I would imagine P3 will be a win. Arb is a nice to have. CVM can hobble along to finish line then partner with someone. If you are looking for exciting day to day moves go buy tech stock.
Gotta love lawyering. Inventiv dragging out as much possible obviously. we're just little shareholders. bigger investors like new cro (with granted block), law firm representing cvm,etc. prob more anxious then us to see this resolved.
We're still trying to recover from that huge market sell off first week of February. Took the wind out of our sails. Cvm chart mimics dow.
20 people/funds just bought 2.5m shares for $4.7m. To me that's looks like confidence. I'm with 'em. Glta. let's cure cancer. Im in long and strong. Let's do this.
Nope. No "last" filing indicating ergomed sold shares. Again a posting of a misleading statement.
Of course they're allowed to sell. Where is there an indication in a filing they have done so?
Nope. That doesn't indicate ergomed sold. Try again.
Because it's not there and that's why the three of you can't type it in your posts. There is no text in s1 for you to produce and certainly no recent filing indicating ergomed dumped their shares.
Put the reference in your post. Yet to see any of you swing traders cite any in any filing verbiage that conclusively says this.
"Trustbaby" and "lux1" post false info
This announces the issuance of shares. Whate page (where) does it say ergomed intends to unload all its shares?
Link? Market taking another beating today.
No. Why would you say that? We went up on large volume. Down on low volume. I don't see any filings to support any inside dumping.
Market forces have not been our friend. I'm not swing trading or abandoning ship. Cvm story still intact. Theyre due damages when inventiv stops throwing delays and I'm guessing p3 a success with watson getting on board, and cro accepting the large block of shares.
One day this will open like dendreon did. cvm still at a $30M market cap is laughable. even in bankruptcy dendreon bought for $500M. cvm story won't end like that though. Amazing facility can scale production.
Theres really no reason why we couldn't run up to 3 or 4 near term even without news. They don't really need cash as P3 is so close. We don't know when they would announce although really it could be anytime if quotas met. Then there are the catalysts like ARB, key patents, large insider buys or large partner buys, coverage, fund buys. etc.
They'll be fine getting to p3 results postings. Especially as stock rises.
yeah that was a great write up. We deserve a target though in a new article of at least $8. Other bios get coverage with targets that represent the baked in possibilities.
a seeking alpha article would be nice right about now
The facility alone worth the market cap
Going to $3 soon
A short squeeze is very possible if this starts to tick up. Usually cvm sees a selloff. It looks like we might see steady accumulation in go forward with the series of great news. There are not a lot of shares outstanding. Squeeze could trigger a catapult.
arb $ is now just nice to have. phase 3 now complete and audited having had successful phase 2 & 1, big pharma will start knocking requesting partnership for distribution. phase 3 could be a bust although with insiders having access to data and accumulating all things point to success. cvm has been diligently working on multikine for many many years. because its a super important drug for treating cancer. the final show of results just around the corner. 2010 when cvm was 100m rumors they were going to be bought. the story is even further and better now. doubt they would sell. at 100m cap they wouldn't sell out.